Kamada LTD income statement

In fiscal 2025, Kamada LTD reported revenue of $180m, up 12.1% on the year before, operating income of $26.2m (a 14.5% margin) and net income of $20.2m, or $0.35 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Kamada LTD: income statement, annual
Fiscal year	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	70	77	103	114	127	133	104	129	143	161	180
Cost of revenue	55	56	71	73	77	86	73	83	87	91	104
Gross profit	15	21	32	41	50	48	30	47	55	70	76
Research and development	17	16	12	10	13	14	11	13	14	15	13
Selling and marketing	0	0	1	0	1	1	1	—	—	—	—
Operating income	−11	−5	7	19	23	19	−1	5	10	20	26
Interest expense	—	—	—	—	—	0	0	3	16	21	—
Income before tax	−11	−5	7	20	23	19	−2	−2	8	13	23
Income tax	—	2	0	−2	1	1	0	0	0	−1	3
Net income	−11	−7	7	22	22	17	−2	−2	8	14	20
Diluted EPS	−$0.31	−$0.18	$0.18	$0.55	$0.55	$0.38	−$0.05	−$0.05	$0.15	$0.25	$0.35
Diluted shares (average)	36m	36m	38m	40m	41m	45m	45m	45m	54m	58m	58m
EBITDA	−9	−3	10	22	26	22	0	12	17	22	28

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: CRON vs KMDA BTMD vs KMDA AMRN vs KMDA KMDA vs OGI

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Kamada LTD's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Kamada LTD.